Vaes, R.D.W.; Reynders, K.; Sprooten, J.; Nevola, K.T.; Rouschop, K.M.A.; Vooijs, M.; Garg, A.D.; Lambrecht, M.; Hendriks, L.E.L.; Rucevic, M.;
et al. Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study. Cancers 2021, 13, 6259.
https://doi.org/10.3390/cancers13246259
AMA Style
Vaes RDW, Reynders K, Sprooten J, Nevola KT, Rouschop KMA, Vooijs M, Garg AD, Lambrecht M, Hendriks LEL, Rucevic M,
et al. Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study. Cancers. 2021; 13(24):6259.
https://doi.org/10.3390/cancers13246259
Chicago/Turabian Style
Vaes, Rianne D. W., Kobe Reynders, Jenny Sprooten, Kathleen T. Nevola, Kasper M. A. Rouschop, Marc Vooijs, Abhishek D. Garg, Maarten Lambrecht, Lizza E. L. Hendriks, Marijana Rucevic,
and et al. 2021. "Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study" Cancers 13, no. 24: 6259.
https://doi.org/10.3390/cancers13246259
APA Style
Vaes, R. D. W., Reynders, K., Sprooten, J., Nevola, K. T., Rouschop, K. M. A., Vooijs, M., Garg, A. D., Lambrecht, M., Hendriks, L. E. L., Rucevic, M., & De Ruysscher, D.
(2021). Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study. Cancers, 13(24), 6259.
https://doi.org/10.3390/cancers13246259
